Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer

ClinicalTrials.gov ID: NCT00688909

Public ClinicalTrials.gov record NCT00688909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label, Single-arm, Multicenter Study to Evaluate the Rheumatological Tolerability of Letrozole as an Adjuvant Breast Cancer Treatment in Postmenopausal Women Who Are Intolerant and Discontinue Anastrozole Due to Grade 2-3 Arthralgia-myalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate whether patients who are intolerant and discontinue anastrozole due to grade 2-3 arthralgia-myalgia have a decrease in rheumatological symptoms while taking letrozole

Study identification

NCT ID
NCT00688909
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
261 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Jun 2009 (Actual)
Completion
Jun 2009 (Actual)
Last update posted
Jun 9, 2021

2008 – 2009

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
Clearview Cancer Center Huntsville Alabama 35805 —
Hematology Oncology Services of Arkansas Little Rock Arkansas 72205 —
Grass Valley Hematology Oncology Grass Valley California 95945 —
Aptium Oncology - Comprehensive Cancer Care of the Desert Palm Springs California 92262 —
Bay Area Cancer Research Group Pleasant Hill California 94523 —
Front Range Specialist Fort Collins Colorado 80528 —
Lynn Cancer Center Boca Raton Florida 33428 —
Florida Cancer Specialists Fort Myers Florida 33916 —
Memorial Cancer Center Hollywood Florida 33021 —
Palm Beach Cancer Specialists West Palm Beach Florida 33401 —
Northeast Georgia Cancer Care, LLC Athens Georgia 30607 —
Augusta Oncology Augusta Georgia 30901 —
Oncology Specialist of North Georgia Gainesville Georgia 30501 —
The Cancer Instiute at Alexian Brothers Elk Grove Village Illinois 60007 —
Evanston Northwestern Hospital Evanston Illinois 60201 —
Edward H. Kaplan MD & Associates - North Shore Cancer Research Associates Skokie Illinois 60076 —
Cancer Care of Kansas Wichita Kansas 67214 —
Kentuckiana Cancer Institute Louisville Kentucky 40202 —
Mercy Hospital Portland Maine 04101 —
Mercey Hospital Baltimore Maryland 21202 —
Maryland Hematology Oncology Associates, PA Baltimore Maryland 21237 —
Suburban Hospital Cancer Program Bethesda Maryland 20817 —
Hematology Oncology Asssociates of Ohio & Michigan Lambertville Michigan 48144 —
Center for Cancer Care and Research St Louis Missouri 63141 —
Ballas Cancer Center, LLC DBA - St Louis St Louis Missouri 63414 —
Southeast Nebraska Hematology & Oncology Consultants Lincoln Nebraska 68516 —
Trinitas Comprehensive Cancer Center Elizabeth New Jersey 07207 —
Hematology-Oncology Assoc of Northern New Jersey Morristown New Jersey 07962 —
Somerset Hematology & Oncology Somerville New Jersey 08876 —
Cooper University Hospital Voorhees Township New Jersey 08043 —
Broom Oncology Binghamton New York 13905 —
Cancer Care of W. NC Asheville North Carolina 28801 —
Marion L. Shepard Cancer Center Washington North Carolina 27889 —
Summa Health System Akron Ohio 44304 —
Mukesh Bhatt, MD, INC. Medina Ohio 44256 —
Berks Hematology Oncology West Reading Pennsylvania 19611 —
South Carolina Oncology Associates Columbia South Carolina 29210 —
The West Clinic Memphis Tennessee 38138 —
Tenessee Oncology Nashville Tennessee 37203 —
Coastal Bend Cancer Center Corpus Christi Texas 78404 —
Center for Oncology Research and Treatment Dallas Texas 75230 —
Central Utah Clinic American Fork Utah 84003 —
Northern Utah Associates Ogden Utah 84403 —
Medical Oncology & Hematology Associates of Northern Virginia Fairfax Virginia 22031 —
Rockingham Memorial Hospital Regional Cancer Center Harrisonburg Virginia 22801 —
Peninsula Cancer Center Newport News Virginia 23601 —
Green Bay Oncologist, St Vincent Hospital Green Bay Wisconsin 54301 —
Oncology Alliance Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00688909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2021 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00688909 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →